LYEL
Lyell Immunopharma Inc
9.70$
-1.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 6,008.2% | -2,074.2% | -1,185.4% | -200.2% | -125,918.5% | -266,219.7% | -416,733.3% | |
| 191.2% | 55.4% | 127.9% | 19.4% | 15,576.9% | 32,182.0% | 32,052.8% | |
| 2,394.5% | 428.8% | 584.0% | 96.7% | 36,218.5% | 54,334.4% | 116,191.7% | |
| 8,643.4% | 511.1% | 940.0% | 91.6% | – | – | – | |
| 16,865.8% | -4.3% | 37.7% | -96.8% | 2,631.5% | -5,114.8% | -27,483.3% | |
| 2,442.5% | 663.8% | 615.1% | 28.7% | 2,066.2% | 760.7% | 2,166.7% | |
| -64,297.3% | -3,526.5% | -1,141.5% | -13.6% | 141,575.4% | 200,695.1% | 150,269.4% | |
| -28.2% | -152.2% | 3,767.5% | -0.5% | -351.5% | 59,034.4% | – | |
| 53,448.4% | 6,147.4% | 3,767.5% | 12.6% | 1,340.8% | 2,173.8% | 140,016.7% | |
| -4,840.6% | 546.7% | 1,440.6% | -201.1% | 16,994.6% | -63,350.8% | -126,447.2% | |
| 3,565.8% | -2,737.9% | -1,800.5% | -228.9% | -127,984.6% | -266,980.3% | -418,900.0% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.